Interleukin-2-inducible T-cell Kinase (ITK) Targeting by BMS-509744 Does Not Affect Cell Viability in T-cell Prolymphocytic Leukemia (T-PLL)

Por Dondorf, Sabine, Schrader, Alexandra, Herling, Marco
Publicado no J Biol Chem (2015)

Nucleotide excision repair as a targetable vulnerability in leukemia

Por Lohmann, Gregor, Schumacher, Björn, Herling, Marco
Publicado no Oncotarget (2017)

The dawn of a new era in treating T-PLL

Por Schrader, Alexandra, Braun, Till, Herling, Marco
Publicado no Oncotarget (2019)

Advances and Perspectives in the Treatment of T-PLL

Por Braun, Till, von Jan, Jana, Wahnschaffe, Linus, Herling, Marco
Publicado no Curr Hematol Malig Rep (2020)

Restoration of DAP Kinase Tumor Suppressor Function: A Therapeutic Strategy to Selectively Induce Apoptosis in Cancer Cells Using Immunokinase Fusion Proteins

Por Tur, Mehmet Kemal, Daramola, Adebukola K., Gattenlöhner, Stefan, Herling, Marco, Chetty, Shivan, Barth, Stefan
Publicado no Biomedicines (2017)

Retinoblastoma Protein Is Frequently Absent or Phosphorylated in Anaplastic Large-Cell Lymphoma

Por Rassidakis, George Z., Lai, Raymond, Herling, Marco, Cromwell, Candy, Schmitt-Graeff, Annette, Medeiros, L. Jeffrey
Publicado em 2004

High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia

Por Herling, Marco, Patel, Kaushali A., Teitell, Michael A., Konopleva, Marina, Ravandi, Farhad, Kobayashi, Ryuji, Jones, Dan
Publicado em 2008

High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia

Por Herling, Marco, Patel, Kaushali A., Weit, Nicole, Lilienthal, Nils, Hallek, Michael, Keating, Michael J., Jones, Dan
Publicado em 2009

TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation

Por Kuraishy, Ali I., French, Samuel W., Sherman, Mara, Herling, Marco, Jones, Dan, Wall, Randolph, Teitell, Michael A.
Publicado em 2007

Extracellular vesicles released from chronic lymphocytic leukemia cells exhibit a disease relevant mRNA signature and transfer mRNA to bystander cells

Por Reiners, Katrin S., Shatnyeva, Olga, Vasyutina, Elena, Bösl, Teresa, Hansen, Hinrich P., Hallek, Michael, Herling, Marco, von Strandmann, Elke Pogge
Publicado no Haematologica (2017)

Differential Expression of BCL-2 Family Proteins in ALK-Positive and ALK-Negative Anaplastic Large Cell Lymphoma of T/Null-Cell Lineage

Por Rassidakis, George Z., Sarris, Andreas H., Herling, Marco, Ford, Richard J., Cabanillas, Fernando, McDonnell, Timothy J., Medeiros, L. Jeffrey
Publicado em 2001

Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute e...

Por Rengstl, Benjamin, Kim, Sooji, Döring, Claudia, Weiser, Christian, Bein, Julia, Bankov, Katrin, Herling, Marco, Newrzela, Sebastian, Hansmann, Martin-Leo, Hartmann, Sylvia
Publicado no PLoS One (2017)

Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells

Por Goncharova, Olga, Flinner, Nadine, Bein, Julia, Döring, Claudia, Donnadieu, Emmanuel, Rikirsch, Sandy, Herling, Marco, Küppers, Ralf, Hansmann, Martin-Leo, Hartmann, Sylvia
Publicado no Cancers (Basel) (2019)

Direct Targeting Options for STAT3 and STAT5 in Cancer

Por Orlova, Anna, Wagner, Christina, de Araujo, Elvin D., Bajusz, Dávid, Neubauer, Heidi A., Herling, Marco, Gunning, Patrick T., Keserű, György M., Moriggl, Richard
Publicado no Cancers (Basel) (2019)

STAT5 is required for lipid breakdown and beta-adrenergic responsiveness of brown adipose tissue

Por Kaltenecker, Doris, Spirk, Katrin, Ruge, Frank, Grebien, Florian, Herling, Marco, Rupprecht, Anne, Kenner, Lukas, Pohl, Elena E., Mueller, Kristina M., Moriggl, Richard
Publicado no Mol Metab (2020)

Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury

Por Bankov, Katrin, Döring, Claudia, Ustaszewski, Adam, Giefing, Maciej, Herling, Marco, Cencioni, Chiara, Spallotta, Francesco, Gaetano, Carlo, Küppers, Ralf, Hansmann, Martin-Leo, Hartmann, Sylvia
Publicado no Cancers (Basel) (2019)

STAT3 Mutation Is Associated with STAT3 Activation in CD30(+) ALK(−) ALCL

Por Andersson, Emma I., Brück, Oscar, Braun, Till, Mannisto, Susanna, Saikko, Leena, Lagström, Sonja, Ellonen, Pekka, Leppä, Sirpa, Herling, Marco, Kovanen, Panu E., Mustjoki, Satu
Publicado no Cancers (Basel) (2020)

Mature T-cell Lymphomagenesis Induced by Retroviral Insertional Activation of Janus Kinase 1

Por Heinrich, Tim, Rengstl, Benjamin, Muik, Alexander, Petkova, Mina, Schmid, Frederike, Wistinghausen, Robin, Warner, Kathrin, Crispatzu, Giuliano, Hansmann, Martin-Leo, Herling, Marco, von Laer, Dorothee, Newrzela, Sebastian
Publicado em 2013

Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity

Por Reiners, Katrin S., Topolar, Daniela, Henke, Alexander, Simhadri, Venkateswara R., Kessler, Jörg, Sauer, Maike, Bessler, Martina, Hansen, Hinrich P., Tawadros, Samir, Herling, Marco, Krönke, Martin, Hallek, Michael, Pogge von Strandmann, Elke
Publicado em 2013

Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden

Por Prinz, Christian, Vasyutina, Elena, Lohmann, Gregor, Schrader, Alexandra, Romanski, Steffen, Hirschhäuser, Christoph, Mayer, Petra, Frias, Corazon, Herling, Carmen D., Hallek, Michael, Schmalz, Hans-Günther, Prokop, Aram, Mougiakakos, Dimitrios, Herling, Marco
Publicado no Mol Cancer (2015)